-
公开(公告)号:US5270339A
公开(公告)日:1993-12-14
申请号:US938164
申请日:1992-12-03
申请人: Kozo Yamamoto , Yoshihide Fuse , Hideyuki Kishida , Naoko Yasuhara , Toshiaki Miwa , Ikuo Katsumi , Takayoshi Hidaka
发明人: Kozo Yamamoto , Yoshihide Fuse , Hideyuki Kishida , Naoko Yasuhara , Toshiaki Miwa , Ikuo Katsumi , Takayoshi Hidaka
IPC分类号: C07D207/08 , C07D207/20 , C07D207/24 , C07D207/26 , C07D207/36 , C07D405/12 , C07D207/06
CPC分类号: C07D207/26 , C07D207/08 , C07D207/20 , C07D207/24 , C07D207/36 , C07D405/12
摘要: There are described a phenoxybenzene derivative having the formula (I): ##STR1## wherein R.sup.1 is hydrogen atom; an alkyl group having 1 to 3 carbon atoms; --OR.sup.6 or a halogen atom,R.sup.2 is hydrogen atom, nitro group or amino group,R.sup.3 is hydrogen atom, an alkyl group having 1 to 8 carbon atoms, a cycloalkyl group having 3 to 5 carbon atoms, allyl group, vinyl group or --(CH.sub.2)n.sup.1 R.sup.7R.sup.4 is hydrogen atom, an alkyl group having 1 to 3 carbon atoms or --(CH.sub.2)n.sup.3 R.sup.25R.sup.5 hydrogen atom; an alkyl group having 1 to 3 carbon atoms; or phenyl group,X is ##STR2## wherein Y is oxygen atom or sulfur atom; or --CHR.sup.27 -- and line means a single bond or a double bond provided that n is 2 in case that the line means a single bond and n is 1 in case that the line means a double bond, ora pharmacologically acceptable salt thereof,a cognition enhancer comprising the same as an effective ingredient andan antidepressant comprising the same as an effective ingredient.
摘要翻译: PCT No.PCT / JP92 / 00410 Sec。 371日期1992年12月3日 102(e)日期1992年12月3日PCT提交1992年4月2日PCT公布。 WO92 / 17447 PCT出版物 描述了具有式(I)的苯氧基苯衍生物:其中R 1是氢原子;(I)其中R 1是氢原子; 具有1至3个碳原子的烷基; -OR 6或卤原子,R 2为氢原子,硝基或氨基,R 3为氢原子,碳原子数1〜8的烷基,碳原子数3〜5的环烷基,烯丙基,乙烯基或 - (CH2)n1R7 R4为氢原子,碳原子数1〜3的烷基或 - (CH2)n3R25 R5氢原子; 具有1至3个碳原子的烷基; 或苯基,X是其中Y是氧原子或硫原子; 或-CHR27-,并且线表示单键或双键,条件是在线表示单键的情况下n为2,并且在该线表示双键的情况下n为1,或其药理学上可接受的盐, 包含与有效成分相同的认知增强剂和包含其作为有效成分的抗抑郁药。
-
公开(公告)号:US5494917A
公开(公告)日:1996-02-27
申请号:US313118
申请日:1994-10-12
申请人: Yoshihide Fuse , Kozo Yamamoto , Hideyuki Kishida , Toshiaki Miwa , Takayoshi Hidaka , Ikuo Katsumi
发明人: Yoshihide Fuse , Kozo Yamamoto , Hideyuki Kishida , Toshiaki Miwa , Takayoshi Hidaka , Ikuo Katsumi
IPC分类号: A61K31/435 , A61K31/55 , A61P25/28 , C07D453/02 , C07D471/08 , C07D487/08 , A61K31/44 , C07D211/72
CPC分类号: C07D453/02
摘要: A cognition enhancer comprising, as an effective ingredient, a bicyclic compound containing nitrogen atom having the general formula (I): ##STR1## or a physiologically acceptable salt thereof.
摘要翻译: PCT No.PCT / JP94 / 00218 Sec。 371日期:1994年10月12日 102(e)日期1994年10月12日PCT 1994年2月4日PCT PCT。 WO94 / 19348 PCT公开号 1994年9月1日。一种认知增强剂,其包含作为有效成分的含有通式(I)的氮原子的双环化合物或其生理学上可接受的盐。
-
公开(公告)号:US5352677A
公开(公告)日:1994-10-04
申请号:US914753
申请日:1992-07-15
申请人: Yoshihide Fuse , Kenji Fujii , Keiji Kameyama , Taizo Kawabe , Toshiaki Miwa , Ikuo Katsumi
发明人: Yoshihide Fuse , Kenji Fujii , Keiji Kameyama , Taizo Kawabe , Toshiaki Miwa , Ikuo Katsumi
IPC分类号: A61K31/495 , C07D295/104 , C07D401/04
CPC分类号: A61K31/495 , C07D295/104 , C07D401/04
摘要: Cinnamamide derivatives and the salts thereof are provided. An antihyperlipidemic composition is also provided. The composition comprises an active ingredient which is at least one selected from the group consisting of the above-mentioned cinnamamide derivative and the pharmaceutically acceptable salt thereof.
摘要翻译: 提供肉桂酰胺衍生物及其盐。 还提供了抗高脂血症组合物。 该组合物包含选自上述肉桂酰胺衍生物和其药学上可接受的盐中的至少一种的活性成分。
-
公开(公告)号:US5294624A
公开(公告)日:1994-03-15
申请号:US914298
申请日:1992-07-15
申请人: Yoshihide Fuse , Kenji Fujii , Keiji Kameyama , Taizo Kawabe , Toshiaki Miwa , Ikuo Katsumi
发明人: Yoshihide Fuse , Kenji Fujii , Keiji Kameyama , Taizo Kawabe , Toshiaki Miwa , Ikuo Katsumi
IPC分类号: C07C235/34 , C07C235/36 , C07C235/88 , C07C237/22 , C07C243/34 , C07C255/29 , C07C255/44 , C07C271/12 , C07C323/41 , C07C323/52 , C07D207/09 , C07D209/14 , C07D211/60 , C07D211/62 , C07D213/40 , C07D213/70 , C07D213/74 , C07D213/79 , C07D213/81 , C07D233/84 , C07D235/28 , C07D239/38 , C07D277/46 , C07D295/135 , C07D295/185 , C07D307/33 , C07D333/20 , C07D521/00 , A61K31/44
CPC分类号: C07D213/40 , C07C235/34 , C07C235/36 , C07C235/88 , C07C237/22 , C07C243/34 , C07C255/29 , C07C255/44 , C07C271/12 , C07C323/41 , C07C323/52 , C07D207/09 , C07D209/14 , C07D211/60 , C07D211/62 , C07D213/70 , C07D213/74 , C07D213/79 , C07D213/81 , C07D231/12 , C07D233/56 , C07D233/84 , C07D235/28 , C07D239/38 , C07D249/08 , C07D277/46 , C07D295/135 , C07D295/185 , C07D307/33 , C07D333/20 , C07C2102/08 , C07C2102/10
摘要: Novel cinnamamide derivatives and the salts thereof are provided. An antihyperlipidemic composition is also provided. The composition comprises an active ingredient which is at least one selected from the group consisting of the above-mentioned cinnamamide derivative and the pharmaceutically acceptable salt thereof.
摘要翻译: 提供了新颖的肉桂酰胺衍生物及其盐。 还提供了抗高脂血症组合物。 该组合物包含选自上述肉桂酰胺衍生物和其药学上可接受的盐中的至少一种的活性成分。
-
公开(公告)号:US5294643A
公开(公告)日:1994-03-15
申请号:US548121
申请日:1990-07-05
申请人: Yoshihide Fuse , Kenji Fujii , Keiji Kameyama , Taizo Kawabe , Toshiaki Miwa , Ikuo Katsumi
发明人: Yoshihide Fuse , Kenji Fujii , Keiji Kameyama , Taizo Kawabe , Toshiaki Miwa , Ikuo Katsumi
IPC分类号: C07C235/34 , C07C235/36 , C07C235/88 , C07C237/22 , C07C243/34 , C07C255/29 , C07C255/44 , C07C271/12 , C07C323/41 , C07C323/52 , C07D207/09 , C07D209/14 , C07D211/60 , C07D211/62 , C07D213/40 , C07D213/70 , C07D213/74 , C07D213/79 , C07D213/81 , C07D233/84 , C07D235/28 , C07D239/38 , C07D277/46 , C07D295/135 , C07D295/185 , C07D307/33 , C07D333/20 , C07D521/00 , A61K31/165 , C07C233/11
CPC分类号: C07D213/40 , C07C235/34 , C07C235/36 , C07C235/88 , C07C237/22 , C07C243/34 , C07C255/29 , C07C255/44 , C07C271/12 , C07C323/41 , C07C323/52 , C07D207/09 , C07D209/14 , C07D211/60 , C07D211/62 , C07D213/70 , C07D213/74 , C07D213/79 , C07D213/81 , C07D231/12 , C07D233/56 , C07D233/84 , C07D235/28 , C07D239/38 , C07D249/08 , C07D277/46 , C07D295/135 , C07D295/185 , C07D307/33 , C07D333/20 , C07C2102/08 , C07C2102/10
摘要: Novel cinnamamide derivatives and the salts thereof are provided. An antihyperlipidemic composition is also provided. The composition comprises an active ingredient which is at least one selected from the group consisting of the above-mentioned cinnamamide derivative and the pharmaceutically acceptable salt thereof.
摘要翻译: 提供了新颖的肉桂酰胺衍生物及其盐。 还提供了抗高脂血症组合物。 该组合物包含选自上述肉桂酰胺衍生物和其药学上可接受的盐中的至少一种的活性成分。
-
6.
公开(公告)号:US5268367A
公开(公告)日:1993-12-07
申请号:US814642
申请日:1991-12-30
申请人: Toshiaki Miwa , Takayoshi Hidaka , Yoji Hisada , Takehiko Ohfuji , Y. Pomeranz
发明人: Toshiaki Miwa , Takayoshi Hidaka , Yoji Hisada , Takehiko Ohfuji , Y. Pomeranz
IPC分类号: A23L1/09 , A23L1/308 , A61K31/715 , A61P3/04 , A61P3/06 , C12P19/14 , A23L1/0522
CPC分类号: C12P19/14 , A23L29/35 , A23L33/21 , A61K31/715 , Y10S426/804 , Y10S426/81 , Y10S514/824 , Y10S514/909 , Y10S514/911
摘要: A cholesterol or body weight regulating material comprising an enzyme resistant starch is disclosed. A composition which contains said enzyme resistant starch is also disclosed. A food, food material, and beverage, containing said enzyme resistant starch are further disclosed. A method for regulating cholesterol or body weight is still further disclosed. Those are effective not only for lowering cholesterol level, but for preventing obesity.
-
-
-
-
-